EcoDrugPlus

Proteasome Subunit Beta 11

Ensembl ID : ENSMMDG00005024426
Gene Symbol: PSMB11
1 Cross references
169 Possible Orthologues:

Proteasome Subunit Beta Type-5-Like

Ensembl ID : ENSMMDG00005024428
Gene Symbol: LOC115375550
3 Cross references
203 Possible Orthologues:

Proteasome Subunit Beta Type-9

Ensembl ID : ENSMMDG00005008741
Gene Symbol: LOC115368357
3 Cross references
210 Possible Orthologues:

Protein Arginine Methyltransferase 5

Ensembl ID : ENSMMDG00005024408
Gene Symbol: PRMT5
3 Cross references
198 Possible Orthologues:

Protein Farnesyltransferase Subunit Beta-Like

Ensembl ID : ENSMMDG00005015161
Gene Symbol: LOC115355764
3 Cross references
209 Possible Orthologues:

Protein Kinase C Alpha

Ensembl ID : ENSMMDG00005020062
Gene Symbol: PRKCA
3 Cross references
213 Possible Orthologues:

Protein Kinase C Beta

Ensembl ID : ENSMMDG00005000782
Gene Symbol: PRKCB
3 Cross references
207 Possible Orthologues:

Protein Kinase C Beta Type-Like

Ensembl ID : ENSMMDG00005003991
Gene Symbol: LOC115358428
3 Cross references
223 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSMMDG00005012353
Gene Symbol: PRKCD
3 Cross references
203 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSMMDG00005021282
Gene Symbol: PRKCD
3 Cross references
204 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSMMDG00005009068
Gene Symbol: PRKCE
1 Cross references
257 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSMMDG00005025030
Gene Symbol: PRKCE
3 Cross references
252 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).